NO319253B1 - Blandinger for behandling av hemoroider og/eller anorektale sykdommer og anvendelse derav. - Google Patents
Blandinger for behandling av hemoroider og/eller anorektale sykdommer og anvendelse derav. Download PDFInfo
- Publication number
- NO319253B1 NO319253B1 NO19972125A NO972125A NO319253B1 NO 319253 B1 NO319253 B1 NO 319253B1 NO 19972125 A NO19972125 A NO 19972125A NO 972125 A NO972125 A NO 972125A NO 319253 B1 NO319253 B1 NO 319253B1
- Authority
- NO
- Norway
- Prior art keywords
- weight
- percent
- mixture
- amount
- water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 71
- 208000014617 hemorrhoid Diseases 0.000 title claims description 23
- 238000011282 treatment Methods 0.000 title claims description 19
- 208000015815 Rectal disease Diseases 0.000 title claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 238000002360 preparation method Methods 0.000 claims description 32
- 241000208680 Hamamelis mollis Species 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 19
- 229940118846 witch hazel Drugs 0.000 claims description 19
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 14
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 14
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 11
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 229960003733 phenylephrine hydrochloride Drugs 0.000 claims description 7
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 claims description 7
- 230000000699 topical effect Effects 0.000 claims description 6
- 239000003349 gelling agent Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000003246 corticosteroid Substances 0.000 claims description 2
- 229960001334 corticosteroids Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- -1 methyl hydroxypropyl Chemical group 0.000 claims 1
- 239000000499 gel Substances 0.000 description 35
- 238000003756 stirring Methods 0.000 description 12
- 230000001050 lubricating effect Effects 0.000 description 11
- 229960001802 phenylephrine Drugs 0.000 description 11
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000000314 lubricant Substances 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 7
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 7
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 7
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 5
- 239000003212 astringent agent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 5
- 235000010262 sodium metabisulphite Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229940001584 sodium metabisulfite Drugs 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- 239000005526 vasoconstrictor agent Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000208690 Hamamelis Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 2
- 229940042129 topical gel Drugs 0.000 description 2
- 208000027185 varicose disease Diseases 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- CAVQBDOACNULDN-KHFUBBAMSA-N (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-KHFUBBAMSA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- 206010061628 Anal infection Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 240000007582 Corylus avellana Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical class OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000208681 Hamamelis virginiana Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- SYCBXBCPLUFJID-UHFFFAOYSA-N Pramoxine hydrochloride Chemical compound Cl.C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 SYCBXBCPLUFJID-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 description 1
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229960003072 epinephrine hydrochloride Drugs 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000007970 homogeneous dispersion Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 229940019974 pramoxine hydrochloride Drugs 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- IUEMQUIQAPPJDL-UHFFFAOYSA-M sodium;2,3-dihydroxypropanoate Chemical compound [Na+].OCC(O)C([O-])=O IUEMQUIQAPPJDL-UHFFFAOYSA-M 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 1
- 229960004291 sucralfate Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9422571A GB9422571D0 (en) | 1994-11-09 | 1994-11-09 | Haemorrihoidal compositions and method of use |
| PCT/GB1995/002629 WO1996014828A1 (en) | 1994-11-09 | 1995-11-09 | Hemorrhoidal compositions and method of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO972125D0 NO972125D0 (no) | 1997-05-07 |
| NO972125L NO972125L (no) | 1997-07-02 |
| NO319253B1 true NO319253B1 (no) | 2005-07-04 |
Family
ID=10764101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19972125A NO319253B1 (no) | 1994-11-09 | 1997-05-07 | Blandinger for behandling av hemoroider og/eller anorektale sykdommer og anvendelse derav. |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US6565850B2 (fi) |
| EP (1) | EP0785770B1 (fi) |
| JP (1) | JP4555402B2 (fi) |
| KR (1) | KR100385247B1 (fi) |
| CN (1) | CN1101181C (fi) |
| AR (1) | AR002944A1 (fi) |
| AT (1) | ATE197122T1 (fi) |
| AU (1) | AU715566B2 (fi) |
| BR (1) | BR9509710A (fi) |
| CA (1) | CA2204769C (fi) |
| CZ (1) | CZ292100B6 (fi) |
| DE (1) | DE69519235T2 (fi) |
| DK (1) | DK0785770T3 (fi) |
| ES (1) | ES2151968T3 (fi) |
| FI (1) | FI119498B (fi) |
| GB (1) | GB9422571D0 (fi) |
| GR (1) | GR3034784T3 (fi) |
| HK (1) | HK1008187A1 (fi) |
| HU (1) | HU221480B (fi) |
| IL (1) | IL115891A (fi) |
| MX (1) | MX9703429A (fi) |
| NO (1) | NO319253B1 (fi) |
| NZ (1) | NZ295211A (fi) |
| PL (1) | PL182403B1 (fi) |
| PT (1) | PT785770E (fi) |
| RO (1) | RO116766B1 (fi) |
| RU (1) | RU2159119C2 (fi) |
| SK (1) | SK283421B6 (fi) |
| TW (1) | TW501932B (fi) |
| WO (1) | WO1996014828A1 (fi) |
| ZA (1) | ZA959438B (fi) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9422571D0 (en) * | 1994-11-09 | 1995-01-04 | Whitehall Lab Ltd | Haemorrihoidal compositions and method of use |
| ATE320796T1 (de) | 1996-12-23 | 2006-04-15 | Sla Pharma Ag | Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz |
| FR2779061B1 (fr) * | 1998-04-14 | 2004-08-20 | Pharmatop | Nouveau procede de stabilisation de composes phenoliques et les compositions pharmaceutiques en resultant |
| JP4473539B2 (ja) * | 2003-08-12 | 2010-06-02 | エスエス製薬株式会社 | 医薬組成物 |
| AU2004292954A1 (en) * | 2003-11-13 | 2005-06-09 | Alza Corporation | Composition and apparatus for transdermal delivery |
| US20050107867A1 (en) * | 2003-11-17 | 2005-05-19 | Taheri Syde A. | Temporary absorbable venous occlusive stent and superficial vein treatment method |
| US20060004094A1 (en) * | 2004-07-02 | 2006-01-05 | Agisim Gary R | Composition and method for treating hemorrhoids and/or anorectal disorders |
| US20060075522A1 (en) * | 2004-07-31 | 2006-04-06 | Jaclyn Cleveland | Genes and uses for plant improvement |
| WO2006026412A2 (en) * | 2004-08-31 | 2006-03-09 | Vnus Medical Technologies, Inc. | Apparatus and material composition for permanent occlusion of a hollow anatomical structure |
| TW200635566A (en) | 2005-01-25 | 2006-10-16 | Vnus Med Tech Inc | Structures for permanent occlusion of a hollow anatomical structure |
| PL2656860T3 (pl) | 2005-06-17 | 2021-11-08 | Wisconsin Alumni Research Foundation | Preparaty środka zwężającego naczynia i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej |
| AU2014202738B2 (en) * | 2005-06-17 | 2016-05-12 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
| AU2016202290B2 (en) * | 2005-06-17 | 2017-10-05 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
| AU2012202731B2 (en) * | 2005-06-17 | 2014-06-19 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
| US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
| US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
| US20070254027A1 (en) * | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| JP5369389B2 (ja) * | 2006-05-25 | 2013-12-18 | 大正製薬株式会社 | 痔疾治療用組成物 |
| US9005652B2 (en) | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
| CN101152166B (zh) * | 2007-09-06 | 2010-12-08 | 武汉大学 | 一种治疗痔病的异甘草素凝胶剂及制备方法 |
| PE20091084A1 (es) * | 2007-12-07 | 2009-07-23 | Schering Plough Healthcare | Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal |
| JP5833919B2 (ja) | 2008-04-24 | 2015-12-16 | メドトロニック，インコーポレイテッド | キトサンと酸化多糖とに基づく保護用ゲル |
| WO2009132228A1 (en) | 2008-04-24 | 2009-10-29 | Medtronic, Inc. | Chitosan-containing protective composition |
| CN106046396B (zh) * | 2008-04-24 | 2019-02-22 | 麦德托尼克公司 | 可再水化的多糖颗粒和海绵体 |
| CA2722145A1 (en) | 2008-04-24 | 2009-10-29 | Medtronic, Inc. | Rehydratable thiolated polysaccharide particles and sponge |
| US20090297643A1 (en) * | 2008-06-02 | 2009-12-03 | Micro-Dose Life Sciences, Llc | Botanical composition and its uses |
| US9545391B2 (en) * | 2010-08-11 | 2017-01-17 | Hemaway Llc | Medicated ointment for treating hemorrhoid and method of using the same |
| ITMI20111732A1 (it) * | 2011-09-27 | 2013-03-28 | Bsdpharma Srl | Formulazioni farmaceutiche per la riduzione della sensibilizzazione crociata tra colon-retto ed il distretto urogenitale con mezzi non-farmacologici. |
| JP5697573B2 (ja) * | 2011-10-14 | 2015-04-08 | 大正製薬株式会社 | 清涼化剤含有ゲル状痔疾治療用剤 |
| US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
| US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
| US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
| US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
| CN103919952A (zh) * | 2014-04-21 | 2014-07-16 | 张维芬 | 一种治疗痔疮的凝胶剂及其制备方法 |
| CN104173344A (zh) * | 2014-09-18 | 2014-12-03 | 杨传爱 | 一种治疗无痛注射痔疮的新疗法 |
| US10039830B2 (en) * | 2016-03-04 | 2018-08-07 | Cetylite Industries, Inc. | Topical anesthetic composition |
| BR102018008324A2 (pt) * | 2018-04-25 | 2019-11-05 | Laboratorios Ferring Ltda | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
| US11576801B2 (en) | 2019-01-24 | 2023-02-14 | Robert S. Cutler | Topical treatment for anorectal disorders with and without seat cushion |
| FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
| IT202000010924A1 (it) * | 2020-05-13 | 2021-11-13 | Neilos S R L | “composizione per la prevenzione e il trattamento di patologie dell’apparato circolatorio e dei sintomi correlati” |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US384522A (en) * | 1888-06-12 | Snow-plow | ||
| US462800A (en) * | 1891-11-10 | Pipe punch and cutter | ||
| US420763A (en) * | 1890-02-04 | Art of manufacturing articles from wood pulp | ||
| US429987A (en) * | 1890-06-10 | Whip-rack | ||
| US631783A (en) * | 1899-04-18 | 1899-08-29 | Reversible Collar Company | Attachment for calendering-machines. |
| US797324A (en) * | 1903-12-10 | 1905-08-15 | Johnspratt Company | Safety-fuse. |
| GB1261881A (en) | 1967-12-04 | 1972-01-26 | Ethichem Ltd | Improvements in or relating to pharmaceutical compositions comprising witch hazel |
| US3839552A (en) * | 1969-06-02 | 1974-10-01 | C Kosti | Composition for the treatment of hypertrophied oral tissue |
| US3987163A (en) * | 1973-07-27 | 1976-10-19 | Burton, Parsons And Company, Inc. | Polystyrene sulfonate containing opthalmic solutions |
| JPS52156913A (en) * | 1976-06-21 | 1977-12-27 | Toko Yakuhin Kogyo Kk | Production of injectionable medicine |
| US4192866A (en) * | 1978-10-10 | 1980-03-11 | Ralph Anderson | Anorectal medication |
| US4383986A (en) * | 1981-08-17 | 1983-05-17 | Ortho Pharmaceutical Corporation | Hemorrhoidal compositions |
| DE3376957D1 (en) | 1982-06-24 | 1988-07-14 | Robert Alan Smith | Pharmaceutical gel composition |
| JPS6121251A (ja) | 1984-07-11 | 1986-01-29 | 鹿島建設株式会社 | プレストレス導入用ｐｃストランド束の挿入方法およびその装置 |
| JPS6228392A (ja) | 1985-07-26 | 1987-02-06 | 株式会社ブリヂストン | 貯槽用通気栓 |
| US4797392A (en) * | 1987-01-27 | 1989-01-10 | Chernomorsky Simon A | Use of anorectal compositions |
| EP0386960A3 (en) * | 1989-03-07 | 1991-10-23 | American Cyanamid Company | Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings |
| GB2229443A (en) * | 1989-03-07 | 1990-09-26 | American Cyanamid Co | Wound dressings |
| US5002675A (en) | 1989-07-13 | 1991-03-26 | Randisi Sal A | Cable pulling compounds |
| GB9422571D0 (en) * | 1994-11-09 | 1995-01-04 | Whitehall Lab Ltd | Haemorrihoidal compositions and method of use |
| US5880076A (en) * | 1997-08-04 | 1999-03-09 | Lever Brothers Company, Division Of Conopco, Inc. | Compositions comprising glycacarbamate and glycaurea compounds |
-
1994
- 1994-11-09 GB GB9422571A patent/GB9422571D0/en active Pending
-
1995
- 1995-04-05 US US08/417,345 patent/US6565850B2/en not_active Expired - Lifetime
- 1995-11-06 IL IL11589195A patent/IL115891A/en not_active IP Right Cessation
- 1995-11-07 ZA ZA959438A patent/ZA959438B/xx unknown
- 1995-11-09 HU HU9702453A patent/HU221480B/hu not_active IP Right Cessation
- 1995-11-09 RU RU97109845/14A patent/RU2159119C2/ru not_active IP Right Cessation
- 1995-11-09 ES ES95936647T patent/ES2151968T3/es not_active Expired - Lifetime
- 1995-11-09 CN CN95197107A patent/CN1101181C/zh not_active Expired - Lifetime
- 1995-11-09 CZ CZ19971392A patent/CZ292100B6/cs not_active IP Right Cessation
- 1995-11-09 AT AT95936647T patent/ATE197122T1/de active
- 1995-11-09 AU AU38503/95A patent/AU715566B2/en not_active Expired
- 1995-11-09 SK SK587-97A patent/SK283421B6/sk not_active IP Right Cessation
- 1995-11-09 CA CA002204769A patent/CA2204769C/en not_active Expired - Fee Related
- 1995-11-09 BR BR9509710A patent/BR9509710A/pt active IP Right Grant
- 1995-11-09 WO PCT/GB1995/002629 patent/WO1996014828A1/en active IP Right Grant
- 1995-11-09 DE DE69519235T patent/DE69519235T2/de not_active Expired - Lifetime
- 1995-11-09 AR ARP950100112A patent/AR002944A1/es not_active Application Discontinuation
- 1995-11-09 PT PT95936647T patent/PT785770E/pt unknown
- 1995-11-09 PL PL95320487A patent/PL182403B1/pl not_active IP Right Cessation
- 1995-11-09 RO RO97-00874A patent/RO116766B1/ro unknown
- 1995-11-09 EP EP95936647A patent/EP0785770B1/en not_active Expired - Lifetime
- 1995-11-09 DK DK95936647T patent/DK0785770T3/da active
- 1995-11-09 KR KR1019970703098A patent/KR100385247B1/ko not_active IP Right Cessation
- 1995-11-09 JP JP51582696A patent/JP4555402B2/ja not_active Expired - Lifetime
- 1995-11-09 NZ NZ295211A patent/NZ295211A/xx not_active IP Right Cessation
-
1996
- 1996-02-27 TW TW085102281A patent/TW501932B/zh not_active IP Right Cessation
-
1997
- 1997-05-07 FI FI971969A patent/FI119498B/fi not_active IP Right Cessation
- 1997-05-07 NO NO19972125A patent/NO319253B1/no not_active IP Right Cessation
- 1997-05-09 MX MX9703429A patent/MX9703429A/es unknown
-
1998
- 1998-07-20 HK HK98109293A patent/HK1008187A1/xx not_active IP Right Cessation
-
2000
- 2000-11-08 GR GR20000402473T patent/GR3034784T3/el unknown
-
2003
- 2003-04-08 US US10/409,359 patent/US20040037888A1/en not_active Abandoned
-
2006
- 2006-09-07 US US11/470,979 patent/US20070003627A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO319253B1 (no) | Blandinger for behandling av hemoroider og/eller anorektale sykdommer og anvendelse derav. | |
| RU2403012C2 (ru) | Мукоадгезивные ксилоглюкансодержащие препараты, полезные в медицинских устройствах и в фармацевтических препаратах | |
| JP2002507561A (ja) | 全身作用を有する局所ホルモン組成物 | |
| CN108348636A (zh) | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 | |
| DK152171B (da) | Salve samt salvegrundlag til fremstilling af en saadan | |
| JP2001507020A (ja) | 大便失禁および肛門掻痒症を治療するための医薬組成物 | |
| MX2011001739A (es) | Composiciones mucoadherentes y sus usos. | |
| US20120264757A1 (en) | Composition and Method for Treating Hemorrhoids and/or Anorectal Disorders | |
| CN108635585A (zh) | 一种治疗老年性阴道炎的药物组合物及温敏缓释凝胶剂和制备方法 | |
| BR112020021572A2 (pt) | Composição farmacêutica tópica de fissuras anais e hemorróidas | |
| JP2007077150A (ja) | 酸−酸緩衝系を含有する無水組成物 | |
| RU2705794C1 (ru) | Комбинированная мягкая лекарственная форма для лечения геморроидальных заболеваний | |
| CN115887357B (zh) | 氨苯砜凝胶制剂及其制备方法 | |
| CN116077523A (zh) | 一种用于防治痔疮的组合物及其制备方法与应用 | |
| JPS6377814A (ja) | 潤滑剤 | |
| WO2017206096A1 (zh) | 一种阿戈美拉汀软胶囊制剂 | |
| Turner | alkaloids: see MORPHINE. | |
| WO2006104676A1 (en) | Ganglionic blocking agents for the treatment of epithelial diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |